Tenaya Therapeutics Inc (TNYA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Tenaya Therapeutics Inc   (NASDAQ: TNYA)


Tenaya Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Tenaya Therapeutics Inc's ROI in the second quarter of 2026?
Tenaya Therapeutics Inc recorded a cumulative net loss of $-103 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -99.13%.

Within the Healthcare sector 627 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3735 to 3927.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -11.03 % -10.62 % -14.43 % -25.56 % -26.24 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 75 118 131 92 109
Return On Investment (TTM) -99.13 % -73.61 % -78.35 % -86.67 % -85.2 %
TNYA's Overall Ranking # 3927 # 3735 # 3120 # 3495 # 3256
Seq. Investment Change TTM -7.75 % -2.49 % 6.33 % -6.98 % -7.33 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -103 -83 -91 -94 -100

TNYA Company Profile >> Back to TNYA Roi Comparisons >> See Annual TNYA Return On Investment



Return On Investment TNYA's Ranking
Within: No.
Industry # 102
Sector # 628
Overall # 3927

Return On Investment Statistics
High Average Low
-41.36 %
-98.62 %
-224.98 %
(Jun 30 2021)   (Sep 30 2022)



  News about Tenaya Therapeutics Inc Return on Investment ROI

Tenaya Therapeutics Revamps Research Leadership to Overcome Financial Challenges and Accelerate Innovative Therapies

June 27, 2024

Tenaya Therapeutics Announces Research Leadership Updates
Tenaya Therapeutics, a leading biotechnology company focused on developing treatments for heart diseases, recently made significant changes to its research leadership team. In a press release, the company announced the promotion of Kathy Ivey, Ph.D., to Senior Vice President of Research, while Timothy Hoey, Ph.D., transitioned into an advisory role. These updates reflect the company s commitment to driving innovative research and development in the field of regenerative medicine.
Dr. Kathy Ivey s promotion to Senior Vice President of Research at Tenaya Therapeutics is a testament to her exceptional contributions to the company. Dr. Ivey, who has been with Tenaya for several years, has played a pivotal role in shaping the company s research strategy through her expertise in cardiovascular biology. Her dedication and leadership have been instrumental in advancing Tenaya s pipeline of novel therapeutics.





Financial Statements
Tenaya Therapeutics Inc's II. Quarter Investments $ 75 Millions TNYA's Balance sheet
Tenaya Therapeutics Inc's II. Quarter Income $ -43 Millions Quarterly TNYA's Income Statement
TNYA's Income by Division See TNYA's Income by Division


TNYA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2020)
2021
Total Investments in Millions 131 104 148 255 367
Y / Y Investment Growth 26.47 % -29.65 % -41.98 % -30.66 % -
Net Income in Millions -91 -111 -124 -124 -38
Y / Y Net Income Growth - - - - -
Annual Return On Investment -68.9 % -106.89 % -83.96 % -48.55 % -10.45 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TNYA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TNYA's Competitors
Subscribers only: Roi for Tenaya Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for TNYA's Customers

Other Ratios
TNYA's Roa TNYA's Inventory Turnover Ratio TNYA's Growth Rates TNYA's Dividend Statistics
TNYA's Profitability Ratios TNYA's Asset Turnover Ratio TNYA's Dividend Growth
TNYA's Roe TNYA's Valuation Ratios TNYA's Financial Strength Ratios TNYA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-10T17:45:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.